McKesson Corporation (MCK) Institutional Ownership & Insider Trading

2,004 institutions reported holding McKesson Corporation shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 20 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

MCKMcKesson CorporationFollow MCK — free

Medical Distribution · Healthcare

—

Price chart with a free account

Market cap: 116.7B
P/E TTM: 26.8
Dividend yield: 0.3%
52-week: —
Next earnings: 4 Nov, in 11 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

2,004 institutions held 90.4% of the shares. Across filers that reported both quarters, shares held changed -2.5%.

Largest moves, shares (millions)

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters

Quarter	Holders	Shares held, M	Change	Increased	New	Decreased	Closed
Jun 26	2,004	105	-2.5%	603	114	692	154
Mar 26	2,011	106	-0.6%	593	128	642	79
Dec 25	1,949	109	-2.8%	573	139	557	59
Sep 25	1,785	109	-0.1%	512	118	527	65
Jun 25	1,755	110	-0.4%	512	132	554	79
Mar 25	1,703	107	+0.1%	496	158	516	76
Dec 24	1,601	109	-3.9%	456	106	532	78
Sep 24	1,505	107	-4.2%	410	67	553	144

McKesson Corporation — questions

Who owns McKesson Corporation stock?: 2,004 institutions reported McKesson Corporation shares in 13F filings for the quarter ended 2026-06-30. The largest: BlackRock, Inc. (9.3%), VANGUARD CAPITAL MANAGEMENT LLC (6.7%), STATE STREET CORP (4.9%).
Are McKesson Corporation insiders buying or selling?: 20 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from McKesson Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.